Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank38
Studio
Year-over-Year Change

Return on equity

Percentile
P38
Within normal range
vs 3Y Ago
-0.5x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
2025-22.56%+21.5%
2024-28.73%+1.3%
2023-29.11%-159.4%
202249.02%+311.8%
2021-23.15%-3.1%
2020-22.46%-146.8%
201948.03%+11.5%
201843.08%-
20170.00%-